Previous Article | Next Article 
Journal of Clinical Microbiology, June 2000, p. 2311-2316, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Dynamics of Meningococcal Long-Term Carriage among
University Students and Their Implications for Mass
Vaccination
D. A. A.
Ala'Aldeen,1,*
K. R.
Neal,2
K.
Ait-Tahar,1
J. S.
Nguyen-Van-Tam,2
A.
English,3
T. J.
Falla,3
P. M.
Hawkey,3 and
R. C. B.
Slack1
Meningococcal Research Group, Divisions of
Microbiology1 and Public
Health,2 University Hospital, Nottingham
University, Nottingham NG7 2UH, and Department of
Microbiology, Leeds University, Leeds,3
United Kingdom
Received 9 December 1999/Returned for modification 22 February
2000/Accepted 5 April 2000
 |
ABSTRACT |
In the 1997-98 academic year, we conducted a longitudinal study of
meningococcal carriage and acquisition among first-year students at
Nottingham University, Nottingham, United Kingdom. We examined the
dynamics of long-term meningococcal carriage with detailed
characterization of the isolates. Pharyngeal swabs were obtained from
2,453 first-year students at the start of the academic year (October),
later on during the autumn term, and again in March. Swabs were
immediately cultured on selective media, and meningococci were
identified and serologically characterized. Nongroupable strains were
genetically grouped using a PCR-based assay. Pulsed-field gel
electrophoresis was used to determine the link between sequential
isolates. Of the carriers initially identified in October, 44.1% (98 of 222) were still positive later on in the autumn (November or
December); 57.1% of these remained persistent carriers at 6 months. Of
the index carriers who lost carriage during the autumn, 16% were
recolonized at 6 months. Of 344 index noncarriers followed up, 22.1%
acquired carriage during the autumn term and another 13.7% acquired
carriage by March. Overall, 43.9% (397 of 904) of the isolates were
noncapsulated (serologically nongroupable); by PCR-based genogrouping,
a quarter of these belonged to the capsular groups B and C. The ratio
of capsulated to noncapsulated forms for group B and C strains was 2.9 and 0.95, respectively. Sequential isolates of persistent carriers
revealed that individuals may carry the same or entirely different
organisms at different times. We identified three strains that clearly
switched their capsular expression on and off at different times in
vivo. One student developed invasive meningococcal disease after
carrying the same organism for over 7 weeks. The study revealed a high
rate of turnover of meningococcal carriage among students.
Noncapsulated organisms are capable of switching their capsular
expression on and off (both ways) in the nasopharynx, and group C
strains are more likely to be noncapsulated than group B strains.
Carriage of a particular meningococcal strain does not necessarily
protect against colonization or invasion by a homologous or
heterologous strain.
 |
INTRODUCTION |
Neisseria meningitidis is
the commonest cause of pyogenic meningitis, capable of causing
outbreaks of invasive disease. A number of these have been reported at
British universities. The natural habitat of N. meningitidis
is the human nasopharynx, from where the organism may invade the
bloodstream, causing bacteremia and a number of different clinical
syndromes depending on the virulence of the meningococcal strain, host
immunity, and other poorly understood factors. These syndromes vary in
severity from transient harmless carriage to fatal meningitis and/or septicemia.
Currently, meningococcal disease is endemic in many parts of the world,
with relatively large-scale outbreaks occurring in many countries. It
is interesting that the highest attack rates of invasive meningococcal
disease in the United Kingdom are in the first year of life
(50/105) and among teenagers (5/105), whereas
the highest carriage rate (5 to 15%) is found among teenagers and
young adults (3). Estimating the rates of carriage across
different groups within a community at any one time is difficult
because several factors potentially affect the results. These include
factors related to the organism, host, environment, and swabbing
techniques and methodological ones relating to number of swabs per
round and the sensitivity of different laboratory methods
(3). Study results are therefore generally underestimates of
true carriage.
Based on antigenic differences in their capsular polysaccharide, 13 serogroups of N. meningitidis have been identified.
Virtually all disease-associated isolates are capsulated, with
serogroups A, B, and C responsible for over 90% of invasive
meningococcal infections worldwide. In the United Kingdom, group B is
responsible for around two-thirds of the cases, followed by group C
(around 30 to 40%). A small minority of United Kingdom cases are due
to a mixture of serogroups A, W135, X, and Y. In contrast, up to half
of the carrier strains are noncapsulated and, therefore, serologically
nongroupable (NG). Until recently, NG isolates were considered
nonpathogenic. However, it is now increasingly clear that capsular
expression is phase variable (16), and the loss of capsule
is believed to enhance the organism's ability to colonize the
nasopharynx. The capsule, vital for evasion of human defense mechanisms, is thought to be expressed upon invasion of the bloodstream or cerebrospinal fluid. However, evidence for capsular switching on and
off (in both directions) in vivo in the same carrier has not been
previously reported.
So far, little is known about the genetic (and clonal) makeup of
strains carried within large communities. The population of
meningococcal carrier strains is known to be more diverse than the
population associated with clinical disease (4).
Nevertheless, only a small number of hypervirulent strains, with a
particular genetic makeup, are thought to be capable of causing
invasive disease and epidemic outbreaks. University students are
considered to be a population at increased risk of invasive
meningococcal disease (12). They originate from various
parts of the country and abroad, and the carriage strains isolated on
the first day(s) of the academic year constitute a representative
sample of the prevalent strains in the country. However, the fate of
individual strains (clones) of meningococci after this mass pooling is
unknown. It is not clear whether a natural genetic equilibrium is
maintained or whether certain clones will eventually dominate.
In the 1997-98 academic year, we carried out a study of meningococcal
carriage among first-year university students in Nottingham, United
Kingdom. During "freshers week," all first-year students were
targeted, and representative population samples in residential halls
were approached again at intervals for reswabbing during the autumn
(November or December) and spring (March) terms.
During freshers week, 2,453 students were screened over 4 consecutive
days. The carriage rate rose rapidly in the first week of the term,
from 6.9% on day 1, through 11.2% on day 2 and 19% on day 3, to
23.1% on day 4 (11). The average carriage rate in residents
of residential halls where shared catering facilities are available
during the first week was 13.9%. By November, the carriage rate was
31.0%, and in December it had reached 34.2%. In March, the rate was
28.0%.
In this paper, we report the dynamics of long-term host-pathogen
interaction and provide strong evidence for the continued susceptibility of individuals to multiple meningococcal carriage and
invasive disease. We also provide the evidence for in vivo switching of
capsular polysaccharide expression, which may have important
implications for future mass immunization with capsule-based conjugate vaccines.
 |
MATERIALS AND METHODS |
Recruitment of students and swabbing.
During the first week
of October 1997 (freshers week), 2,453 of the first-year intake of
students in Nottingham University were recruited and swabbed for
meningococcal carriage (11); those residing in halls on
campus where shared catering facilities are available were reswabbed in
the first week of either November or December. A fourth round of
swabbing in five randomly selected halls was undertaken in March 1998.
Culture and characterization of isolates.
Pharyngeal swabs
were taken using cotton swabs and plated immediately onto a selective
medium, GC agar (Oxoid) containing vancomycin, colistin, nystatin, and
trimethoprim (VCNT selective supplement SR91; Oxoid). The plates were
then incubated within 3 h of collection at 37°C in air with 5%
carbon dioxide and examined at 24 and 48 h.
Typical colonies suggestive of Neisseria spp. were examined
for positive oxidase reaction, and a single colony was then subcultured onto a new GC plate (with no antibiotics) to obtain pure cultures for
further characterization. Overnight cultures were then tested by the
Gonocheck system (EY Inc.) according to the manufacturer's instructions. All isolates identified as meningococci were frozen as
duplicate samples, one of which was subsequently sent to the Meningococcal Reference Unit (Manchester Public Health Laboratory, Manchester, United Kingdom) for confirmation of the identification and
serological characterization (6).
PCR-based genogrouping of the serologically NG isolates.
A
total of 112 strains of N. meningitidis, previously
characterized in the Meningococcal Reference Unit, were used in the developmental stage of the PCR assay. These included 3 reference strains (group A, NCTC 10025; group B, NCTC 10026; and group C, NCTC
8554) and 109 laboratory isolates, including 4 of group A, 49 of group
B, 23 of group C, 9 of group 29E, 2 of group H, 7 of group W135, 6 of
group X, 5 of group Y, and 4 of group Z. In addition, clinical isolates
of Neisseria gonorrhoeae, Escherichia coli,
Klebsiella pneumoniae, Pseudomonas aeruginosa,
Haemophilus influenzae, Streptococcus pneumoniae,
and Streptococcus agalactiae were also used as negative controls.
Oligonucleotide primers were designed using the
siaD
sequence specific to capsular groups B and C, to amplify DNA fragments
of a capsule-specific size (786 and 634 bp for groups B and C,
respectively). The primers were designed from the group B sequence
(EMBL accession no.
M64289) and the group C sequence (GenBank
U75650)
(
16) and were as follows: group B
siaD forward,
677GTTAGTCAACGCTACC
692, and reverse,
1463GGAGATCAGAAGTCAT
1448; group
C
siaD forward,
529GTGGGTAACAACTTACA
545, and
reverse,
1163CCATCCTCTATACTTG
1148.
A fresh single colony per isolate was suspended in 300 µl of Chelex
extraction buffer (Bio-Rad), heated to 100°C for 20 min,
and
centrifuged in a microcentrifuge (MSE Micro Centaur) at
13,000
rpm for 30 s. A 10
2 or
10
3 dilution of the supernatant was then used as template
in the
PCR, which consisted of 30 cycles of denaturation (95°C,
30 s),
annealing (45°C, 1 min), and extension (72°C, 1
min).
PFGE.
Comparative genetic analysis was carried out on
selected strains, using pulsed-field gel electrophoresis (PFGE) as
described by Bevanger and colleagues (2).
 |
RESULTS |
Characterization of index carrier meningococcal isolates: capsular
expression and distribution of serogroups, types, and subtypes.
Overall, 904 meningococcal isolates were obtained during the study
period, and they were serologically grouped, typed, and subtyped. Table
1 shows that 30.5% of the isolates
belonged to the more virulent serogroups B and C; 25.6% belonged to
the apparently less virulent serogroups 29E, H, W135, X, Y, and Z; and
up to 43.9% of isolates were NG. According to serological markers,
virtually all of the phenotypically distinct strains, which were found
in October, continued to be represented, although in varying ratios, throughout the academic year (data available on request). Serogroup H,
first isolated in China (15), was found in only two
individuals at the beginning of the academic year but not in subsequent
rounds of swabbing.
With regard to serotype distributions, there were more serologically
nontypeable (NT) strains than typeable ones (data available
on
request). For example, 38% (84 of 222) of all the serogroup
B strains
were NT, compared with 29.3 and 25% for serotypes 1
and 4, respectively. Similarly, serologically nonsubtypeable (NST)
strains
were also more prevalent than any individual subtypeable
ones (data not
shown). For example, among the 85 serogroup B strains
in October, there
were 19 NST strains, compared to 17, 10, 9,
and 8 strains expressing
serosubtype 15, 14, 9, and 4 antigens,
respectively.
Serogroups B and C comprised 54.5% of all capsulated, serogroupable
strains. In order to determine proportions of group B
and C strains
among the NG isolates, a PCR-based genogrouping
assay was developed.
This technique correctly amplified 49 of
49 known group B and 23 of 23 known group C strains, with no false
negatives. No false-positive
results were obtained from 60 capsulated
non-group B or -C
N. meningitidis isolates or the other nonmeningococcal
capsulated
bacteria examined (see Materials and
Methods).
A random sample of 53 NG isolates from the October round of swabbing
was then selected for PCR-based genogrouping. Eight (15.1%)
of these
genogrouped as B, and six (11.3%) genogrouped as C. This
is in
contrast to the ratio of their serogroupable counterparts
among the
capsulated isolates (43.8 and 10.7%, respectively).
The ratio of
capsulated to noncapsulated isolates was greater
among group B strains
than among group C strains. Also, the ratio
of group B to group C
strains among capsulated isolates was significantly
greater than among
the noncapsulated (NG) isolates (Fisher's exact
test [two-tailed]:
P < 0.05) (Table
2).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Proportions (percents) and different ratios of capsular
group B and C strains among the capsulated (excluding NG) and
noncapsulated (NG-only) meningococci
|
|
Dynamics of long-term carriage. (i) Turnover of carriage.
The
follow-up results for the 630 index carriers and noncarriers who were
reswabbed at least once more during the course of the academic year are
shown in Fig. 1. Of the 222 index
carriers reswabbed in autumn, 98 (44.1%) were still positive for
N. meningitidis. Of the latter, 28 were screened again in
March, of whom 16 (57.1%) continued to harbor meningococci. One
hundred twenty-four (55.9%) index carriers apparently cleared the
organism by the end of autumn. Twenty-five of these were reexamined in
March, and four (19%) were found to be recolonized, indicating that
the individual remained susceptible to subsequent meningococcal
carriage despite eradication following an episode of colonization.
Figure 1 also shows another 15 index carriers who were reswabbed in
March (not in autumn), and more than half of these were clearly
persistent carriers. In all, 68 index carriers were rescreened at 6 months and 28 (41.2%) were still carriers.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 1.
Long-term follow-up of index carriers and noncarriers.
+ve, positive; ve, negative; ND, not determined.
|
|
Of students who entered the university as noncarriers, 344 were
reexamined in autumn and spring; 268 (77.9%) persisted as
noncarriers
in autumn; 76 (22.1%) became colonized in autumn,
and another 47 (13.7%) became colonized by March. Two hundred
twenty-one (64.2%)
were apparently persistent
noncarriers.
(ii) Identity of sequential isolates in persistent carriers.
To see whether persistent carriers predominantly harbored the same or
different strains during their carriage period, the capsular serogroups
of the sequential (paired) isolates from the 98 individual carriers in
October who remained positive in the autumn were compared (Table
3). Almost a third of the autumn-round isolates expressed the same capsular serogroup as their paired index
isolates, but only six of these expressed matching serotypes and
subtype antigens (data not shown). The rest either expressed different
type and subtype epitopes or were NT and NST (data available on
request). Thus, based on serological markers alone, only six pairs of
the sequential isolates can be considered highly likely to be the same.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Comparison of the capsular serogroups of sequential
isolates obtained from individual persistent carriers in October
and autumn rounds
|
|
Table
4 shows details of the serological
markers and the results of PFGE carried out on all sequential clinical
isolates
of the 16 persistent carriers, who were confirmed positive on
all three rounds of swabbing. The serological characterization
of the
isolates suggested that only students S1 to S3 carried
single strains
over the 6-month period. The PFGE experiments,
however, confirmed that
these three students, and an additional
four (S4 to S7) carried single
strains from October until March,
highlighting the unreliable nature of
serological markers for
linking strains. The other nine students (S8 to
S16) were colonized
with genetically and serologically heterologous
strains at various
time points over the 6-month period.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Serological characterization and PFGE results for all the
sequential isolates from 16 persistent carriers
|
|
(iii) Evidence for in vivo capsular switching.
The three
individual strains carried by students S5 to S7 had all clearly changed
their serological markers at different points in time, including their
capsular polysaccharide expression (Table 4). The strain carried by
student S5 lost its capsule in March, whereas that of student S6
regained its capsule in autumn after being NG in October. The strain
carried by student S7 was noncapsulated in October, switched on its
capsular expression in autumn, and reverted to NG status in March. The
PFGE profiles of S5 to S7 are shown in Fig.
2.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 2.
PFGE profile of sequential isolates of students S5 to
S8. Oct, October; Dec, December; Mar, March.
|
|
(iv) Evidence for recolonization or simultaneous carriage.
The
serological markers and PFGE profiles of the first and third isolates
of students S8 (Fig. 2) and S9 (data not shown) were indistinguishable.
 |
DISCUSSION |
We studied the dynamics of interaction between meningococci and
university student populations during the course of an academic year.
In total, 904 meningococcal isolates were obtained; almost a third
belonged to the more virulent serogroups B and C, and up to 43.9% were
NG. The NG isolates consisted of a heterogeneous mixture of
noncapsulated strains belonging to all capsular groups. Whereas
serogroups B and C comprised more than half of all capsulated serogroupable strains, the proportion of the these two groups among the
NG isolates was 26.4%. The ratio of capsulated to noncapsulated isolates seems to be lower among the non-B non-C strains (0.62) than
among B and C ones. More interestingly, this ratio was greater among
group B strains than among group C strains (2.9 versus 0.95, respectively). Also, the ratio of group B to group C strains among capsulated isolates was significantly greater than that among NG
isolates. These data suggest that group C strains are more likely to
switch off their capsular expression than group B ones. This may be due
to greater pressure on serogroup C strains, generated by their more
immunogenic capsule, compared with serogroup B. In this context, it
will be interesting to see what impact mass vaccination with conjugated
serogroup C vaccines will have on the carriage rate and/or capsular
expression of serogroup C strains. Conventional capsular polysaccharide
vaccines against serogroup C appear to have little impact on
nasopharyngeal carriage of the organism. Recently, a number of
large-scale phase II clinical trials were carried out on new-generation
conjugated group C capsular polysaccharide vaccines (9, 10).
These have been followed more recently by mass immunization in the
United Kingdom covering all age groups up to university undergraduate
level. In view of the recent findings that serogroup B and C strains
can exchange capsular genes (16, 17), there may be a risk of
forcing such escape mechanisms on hypervirulent strains as a result of
the increased level of herd immunity generated by mass vaccination. It
is therefore important to be aware of this risk during surveillance before and after mass vaccination. Conventional methods of
meningococcal surveillance, based on morbidity and mortality combined
with phenotypic characterization of isolates, will not detect capsular
switching by hypervirulent strains or determine the success of
vaccination. In collaboration with five other United Kingdom centers,
we have recently embarked on a major "molecular surveillance"
project to monitor pre- and postvaccination changes in the circulating meningococcal population. Large population samples (around 15,000 students), consisting of 15- to 16-year-old adolescents, have been
swabbed before the recent vaccination campaign and will be reswabbed
annually over the next 2 years. All meningococcal isolates will be
subjected to multilocus sequence typing, in order to study their
genetic structures and detect any possible changes in capsular expression of the currently prevalent group C strains, which belong to
the ET-37 complex.
In this study, follow-up of index carriers and noncarriers during the
course of the academic year indicated that individuals may carry
meningococci for short or long periods (over 6 months) and those who
eradicate one episode of meningococcal carriage remain susceptible to
subsequent colonizations. Of students who entered the university as
noncarriers, almost two-thirds were negative when screened in autumn
and spring. These have been previously labeled persistent noncarriers.
However, it is important to remember that the putative persistent
noncarriers may have also carried an organism at some point in the past
(or between swabs) but cleared it prior to swabbing. An alternative
explanation is that their carriage (at the time of swabbing) was below
detection threshold. The high turnover of carriage and continued
susceptibility to further colonization suggest that the organism
colonizes different individuals at different points in time and that
most students are potential targets. This would secure continued
circulation of the various meningococcal clones in the community, and
conversely, the student population might gradually acquire herd
immunity against the circulating strains.
From the serological markers alone, it appears that virtually all of
the phenotypically distinct strains, which were found in October,
continued to be represented, although to varying ratios, throughout the
academic year (data available on request). The proportion of the
individual capsular groups, types, and subtypes fluctuated only
marginally during the course of the academic year, suggesting that
there may be a relatively stable natural equilibrium among the carried
meningococcal population in this setting. A similar observation was
made in the study reported by Andersen et al. which was carried out
over a 3-month period on military recruits (1). In contrast,
Jones and colleagues studied nine military recruits who acquired
meningococci during the course of 30 weeks of basic training
(8). They found that a dominant strain carried by one
individual at the start of the course later colonized six more
individuals by the end of the course. Although the study population was
too small to provide solid conclusions, this observation may suggest
that some strains (clones) are capable of displacing others in the
carried meningococcal population. The fact that military recruits train
and associate in small platoon-strength groups with considerable
intimacy may explain why one clone can predominate. In contrast, in a
larger university campus, the social interaction among students is more
diverse and individuals are exposed less-continuously to a greater
number of other persons. This phenomenon deserves further detailed
examination. Similarly, the effect of the summer vacation on the
meningococcal population and the fate of individual strains is also unknown.
Little is known about the host-pathogen interaction during long-term
carriage, and it is not entirely clear whether the persistent carriers
predominantly harbor the same or different strains during their
carriage period. In this study, it is evident that carriage of
particular strains did not prevent colonization with a heterologous strain; this is in agreement with the findings of Jones et al. (8). Given that a third of the autumn-round isolates
expressed the same capsular serogroup as their paired index isolates
(Table 3) but that only six could be considered highly likely to be the
same, it is clear that capsular phase variation, coupled with the
hypervariability of serotype and subtype antigens, makes it extremely
difficult to rely on serological markers to determine the fate of
individual meningococcal isolates or the clonal relation of
disseminated strains. This latter issue is of epidemiological and
public health importance during epidemic outbreaks of meningococcal disease. Only molecular techniques, such as PFGE and multilocus sequence typing, are sufficiently reliable ways to trace and link virulent strains (18).
The fact that the three individual strains carried by students S5 to S7
(Table 4) had all clearly changed their serological markers, including
their capsular polysaccharide expression, at different points in time
and yet were genetically indistinguishable demonstrates meningococcal
in vivo capsular switching (on and off in both directions) among
carriers. Very often, outbreak strains are not identified among
carriers during outbreak investigations (e.g., in Cardiff University,
Cardiff, and Southampton University, Southampton, United Kingdom)
because only serologically groupable isolates are examined. Therefore,
when searching for particular hypervirulent strains among carriers
(e.g., during outbreaks), all NG isolates ought to be genogrouped for
the capsular group in question.
The serological markers and PFGE profile of the first and third
isolates of students S8 and S9 were indistinguishable, suggesting that
the students were recolonized in March by their October isolates after
harboring a heterologous strain in autumn (Fig. 2). If this were the
case, it would imply that meningococcal carriage may not protect
against even the homologous strain, let alone a heterologous one.
Alternatively, these students might have carried both strains simultaneously at all times, but we failed to detect them together during the laboratory identification process, because we examined only
pure growths originating from single colonies on the original culture
plates. Andersen et al. (1) showed that a small minority (15 of 1,777) of swabs from military recruits yielded two simultaneous phenotypically distinct isolates of meningococci. Moreover, multiple isolates from patients with invasive meningococcal disease, where two
distinct isolates were isolated (blood and cerebrospinal fluid samples)
from the same patient have also been reported previously (5).
It has been suggested elsewhere that individuals acquiring new strains
are at greater risk of invasive meningococcal disease and that carriage
of Neisseria spp. protects against disease (7, 14). During the course of the autumn term, two students who were
noncarriers in the first week of October developed invasive meningococcal disease. However, one student, who carried
Neisseria lactamica in October and a serogroup B:NT:P1.4
strain in December, developed meningococcal meningitis in late January
with an indistinguishable strain (13). This clearly
indicates that nasopharyngeal carriage of N. meningitidis or
N. lactamica will not necessarily protect against invasion
even by the same meningococcal strain. There has been some interest in
using commensal Neisseria bacteria or attenuated N. meningitidis as a potential live vaccine against meningococcal
infection. Our findings suggest that this approach requires careful consideration.
 |
ACKNOWLEDGMENTS |
This project was partially supported by a grant from the
Meningitis Research Foundation and Sir Halley Stewart's Trust.
We thank Keith Ashford and Carol Webster for their assistance during
the initial isolation and molecular characterization of strains and the
Meningococcal Reference Unit in Manchester for the serological
characterization of all the meningococcal isolates.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Meningococcal
Research Group, Division of Microbiology, University Hospital,
Nottingham University, Nottingham NG7 2UH, United Kingdom. Phone: 44 115 924 9924, ext. 44952. Fax: 44 115 970 9233. E-mail:
daa{at}nottingham.ac.uk.
 |
REFERENCES |
| 1.
|
Andersen, J.,
L. Berthelsen,
B. Bech-Jensen, and I. Lind.
1998.
Dynamics of meningococcal carrier state and characterisation of the carrier strains: a longitudinal study within three cohorts of military recruits.
Epidemiol. Infect.
121:85-94[CrossRef][Medline].
|
| 2.
|
Bevanger, L.,
G. Bergh,
D. A. Caugant, and L. O. Froholm.
1998.
Identification of nasopharyngeal carriage of an outbreak strain of Neisseria meningitidis by pulsed-field gel electrophoresis versus phenotypic methods.
J. Med. Microbiol.
47:993-998[Abstract/Free Full Text].
|
| 3.
|
Cartwright, K.
1995.
Meningococcal carriage and disease, p. 114-146.
In
K. Cartwright (ed.), Meningococcal disease. John Wiley and Sons, Chichester, United Kingdom.
|
| 4.
|
Caugant, D. A.,
B. E. Kristiansen,
L. O. Froholm,
K. Bovre, and R. K. Selander.
1988.
Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers.
Infect. Immun.
56:2060-2068[Abstract/Free Full Text].
|
| 5.
|
Communicable Disease Report.
1998.
Diagnosis of meningococcal disease by throat swab.
Commun. Dis. Rep.
8:49.
|
| 6.
|
Frasch, C. E.,
W. D. Zollinger, and J. T. Poolman.
1985.
Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.
Rev. Infect. Dis.
7:504-510[Medline].
|
| 7.
|
Gold, R.,
I. Goldschneider,
M. L. Lepow,
T. F. Deaper, and M. Randolph.
1978.
Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children.
J. Infect. Dis.
137:112-121[Medline].
|
| 8.
|
Jones, G. R.,
M. Christodoulides,
J. L. Brooks,
A. R. O. Miller,
K. A. V. Cartwright, and J. E. Heckels.
1998.
Dynamics of carriage of Neisseria meningitidis in a group of military recruits: subtype stability and specificity of the immune response following colonisation.
J. Infect. Dis.
178:451-459[Medline].
|
| 9.
|
MacDonald, M. E.,
S. A. Halperin,
B. J. Law,
B. Forrest,
L. E. Danzig, and D. M. Granoff.
1998.
Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers. A randomized controlled trial.
JAMA
280:1685-1689[Abstract/Free Full Text].
|
| 10.
|
Miller, E.,
P. Richmond,
R. Borrow,
E. Kaczmarski,
K. Cartwright,
R. Morris, and C. Thornton.
1998.
UK strategy for introduction of meningococcal C conjugate vaccines, p. 57.
In
X. Nassif, M.-J. Quentin-Millet, and M.-K. Taha (ed.), Eleventh international pathogenic Neisseria conference. EDK, Paris, France.
|
| 11.
|
Neal, K. R.,
J. S. Nguyen-Van-Tam,
N. Jeffrey,
R. C. B. Slack,
R. J. Madeley,
K. Ait-Tahar,
K. Job,
M. C. J. Wale, and D. A. A. Ala'Aldeen.
2000.
Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross-sectional study.
Br. Med. J.
320:846-849[Abstract/Free Full Text].
|
| 12.
|
Neal, K. R.,
J. S. Nguyen-Van-Tam,
P. Monk,
S. J. O'Brien,
J. Stuart, and M. Ramsay.
1999.
Invasive meningococcal disease among universities providing relatively large amounts of catered hall accommodations.
Epidemiol. Infect.
122:351-357[CrossRef][Medline].
|
| 13.
|
Neal, K. R.,
J. S. Nguyen-Van-Tam,
R. C. B. Slack,
E. B. Kaczmarski,
A. White, and D. A. A. Ala'Aldeen.
1999.
Seven week interval between acquisition of a meningococcus and the onset of invasive disease.
Epidemiol. Infect.
123:507-509[CrossRef][Medline].
|
| 14.
|
Reller, L. B.,
R. R. MacGregor, and H. N. Beaty.
1973.
Bactericidal antibody after colonization with Neisseria meningitidis.
J. Infect. Dis.
127:56-62[Medline].
|
| 15.
|
Shao-Qing, D.,
Y. Ren-Bang, and Z. Huan-Chun.
1981.
Three new serogroups of Neisseria meningitidis.
J. Biol. Stand.
9:307-315[CrossRef][Medline].
|
| 16.
|
Swartley, J. S.,
A. A. Marfin,
S. Edupuganti,
L.-J. Liu,
P. Cieslak,
B. Perkins,
J. D. Wenger, and D. S. Stephens.
1997.
Capsule switching of Neisseria meningitidis.
Proc. Natl. Acad. Sci. USA
94:271-276[Abstract/Free Full Text].
|
| 17.
|
Vogel, U.,
H. Claus, and M. Frosch.
2000.
Rapid serogroup switching in Neisseria meningitidis.
N. Engl. J. Med.
342:219-220[Free Full Text].
|
| 18.
|
Vogel, U.,
G. Morelli,
K. Zurth,
H. Claus,
E. Kriener,
M. Achtman, and M. Frosch.
1998.
Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from healthy contacts.
J. Clin. Microbiol.
36:2465-2470[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, June 2000, p. 2311-2316, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gorringe, A. R., Taylor, S., Brookes, C., Matheson, M., Finney, M., Kerr, M., Hudson, M., Findlow, J., Borrow, R., Andrews, N., Kafatos, G., Evans, C. M., Read, R. C.
(2009). Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles. CVI
16: 1113-1120
[Abstract]
[Full Text]
-
O'Dwyer, C. A., Li, M.-S., Langford, P. R., Kroll, J. S.
(2009). Meningococcal biofilm growth on an abiotic surface - a model for epithelial colonization?. Microbiology
155: 1940-1952
[Abstract]
[Full Text]
-
Bayliss, C. D., Hoe, J. C., Makepeace, K., Martin, P., Hood, D. W., Moxon, E. R.
(2008). Neisseria meningitidis Escape from the Bactericidal Activity of a Monoclonal Antibody Is Mediated by Phase Variation of lgtG and Enhanced by a Mutator Phenotype. Infect. Immun.
76: 5038-5048
[Abstract]
[Full Text]
-
Kelly, D. F., Pollard, A. J., Moxon, E. R.
(2005). Immunological Memory: The Role of B Cells in Long-term Protection Against Invasive Bacterial Pathogens. JAMA
294: 3019-3023
[Abstract]
[Full Text]
-
Jordens, J. Z., Williams, J. N., Jones, G. R., Christodoulides, M., Heckels, J. E.
(2004). Development of Immunity to Serogroup B Meningococci during Carriage of Neisseria meningitidis in a Cohort of University Students. Infect. Immun.
72: 6503-6510
[Abstract]
[Full Text]
-
Yazdankhah, S. P., Caugant, D. A.
(2004). Neisseria meningitidis: an overview of the carriage state. J Med Microbiol
53: 821-832
[Abstract]
[Full Text]
-
Comanducci, M., Bambini, S., Caugant, D. A., Mora, M., Brunelli, B., Capecchi, B., Ciucchi, L., Rappuoli, R., Pizza, M.
(2004). NadA Diversity and Carriage in Neisseria meningitidis. Infect. Immun.
72: 4217-4223
[Abstract]
[Full Text]
-
Bennett, D. E., Mulhall, R. M., Cafferkey, M. T.
(2004). PCR-Based Assay for Detection of Neisseria meningitidis Capsular Serogroups 29E, X, and Z. J. Clin. Microbiol.
42: 1764-1765
[Abstract]
[Full Text]
-
Harrison, O. B., Robertson, B. D., Faust, S. N., Jepson, M. A., Goldin, R. D., Levin, M., Heyderman, R. S.
(2002). Analysis of Pathogen-Host Cell Interactions in Purpura Fulminans: Expression of Capsule, Type IV Pili, and PorA by Neisseria meningitidis In Vivo. Infect. Immun.
70: 5193-5201
[Abstract]
[Full Text]
-
Robinson, K., Neal, K. R., Howard, C., Stockton, J., Atkinson, K., Scarth, E., Moran, J., Robins, A., Todd, I., Kaczmarski, E., Gray, S., Muscat, I., Slack, R., Ala'Aldeen, D. A. A.
(2002). Characterization of Humoral and Cellular Immune Responses Elicited by Meningococcal Carriage. Infect. Immun.
70: 1301-1309
[Abstract]
[Full Text]
-
Jordens, J. Z., Williams, J. N., Jones, G. R., Heckels, J. E.
(2002). Detection of Meningococcal Carriage by Culture and PCR of Throat Swabs and Mouth Gargles. J. Clin. Microbiol.
40: 75-79
[Abstract]
[Full Text]